Screener
MoonLake Immunotherapeutics MLTX Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from MoonLake Immunotherapeutics’s reported figures.
Based on the most recent quarter.
The source filing: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 8:55 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001821586-26-000007
FAQ
- What is MoonLake Immunotherapeutics's book value per share?
- MoonLake Immunotherapeutics (MLTX) reported book value per share of $3.56 in Q1 2026.
- How has MoonLake Immunotherapeutics's book value per share changed year-over-year?
- MoonLake Immunotherapeutics's book value per share decreased by 44.7% year-over-year, from $6.44 to $3.56.
- What is the long-term trend for MoonLake Immunotherapeutics's book value per share?
- Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's book value per share has grown at a 33.5% compound annual growth rate (CAGR), from -$1.49 to $4.72.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about MoonLake Immunotherapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude